SK bioscience

본문바로가기

사이트맵 닫기

PR

SK bioscience company news updates

Press releases

SK bioscience Announces the Largest Investment Ever to Establish Songdo Global Research & Process Development Center

2023.02.08
SK bioscience Achieves ISO 27001 Certification

2023.02.07
SK bioscience Receives Upgrade MSCI ESG Rating

2023.02.03
SK bioscience’s World-First Cell Culture-Based Quadrivalent Influenza Vaccine Is Approved in Chile

2023.02.02
SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs

2023.01.27
SK bioscience Appoints New Executives to Accelerate New Growth Strategies

2023.01.20
SK bioscience’s Shingles Vaccine Receives Biologics License Application Approval in Malaysia

2023.01.09
SK bioscience Receives ‘Grade A’ Rating on ESG Evaluation from the Korea Institute of Corporate Governance & Sustainability

2022.11.25
SK bioscience Donates to International Vaccine Institute to Support Global Vaccine R&D

2022.11.17
SK bioscience Announces New Strategy for Continuous Growth

2022.11.01